Rheumatology, Department of Endocrinology, Diabetology and Rheumatology, Heinrich-Heine University of Düsseldorf, Germany.
Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S19-24.
To gain insight into the immune pathogenesis of Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA), the prevalence of circulating CD8+ T lymphocytes expressing CD57 as a marker for previous activation was analyzed.
Receptor expression of CD57 was measured in CD8+ T cells of patients with active disease (n=5) by cytofluorometry and compared with expression in patients in remission (n=80) and in age-matched healthy donors (n=34). The results were compared to clinical parameters including severity and duration of the disease.
CD8+CD57+ were detected in patients with WG and MPA and in healthy donors as well and increased considerably with age. Compared to age-matched healthy donors, the prevalence of CD8+CD57+ was increased in the younger patients (up to 40 y). In most patients a high percentage of CD8+CD57+ coincided with severe disease and multiple organ involvement, while low CD8+CD57+ percentage was seen in patients with limited disease or in patients in complete remission. In patients with smoldering disease, the percentage of CD8+CD57+ increased with time. High numbers of CD8+CD57+ correlated with low CD4:CD8 ratio.
In patients with WG and MPA a population of CD8+CD57+ expand, identifying terminally differentiated CD8+ cells. The prevalence of CD57+ cells was related to the course of disease. So far, the function of CD57 on CD8+ cells is not understood. However, these cells might produce certain cytokines, which play a role in the pathogenesis of AAV. The data support the hypothesis that CD8+ T cells are activated in the context of primary vasculitides.
深入了解 Wegener 肉芽肿病(WG)和显微镜下多血管炎(MPA)的免疫发病机制,分析循环 CD8+T 淋巴细胞表达 CD57 的流行情况,CD57 作为先前激活的标志物。
通过细胞荧光术测量处于活动期疾病(n=5)患者的 CD8+T 细胞中 CD57 的受体表达,并将其与缓解期患者(n=80)和年龄匹配的健康供体(n=34)的表达进行比较。结果与包括疾病严重程度和持续时间在内的临床参数进行了比较。
在 WG 和 MPA 患者以及健康供体中均检测到 CD8+CD57+,并且随着年龄的增长而显著增加。与年龄匹配的健康供体相比,年轻患者(直至 40 岁)的 CD8+CD57+患病率增加。在大多数患者中,高比例的 CD8+CD57+与严重疾病和多器官受累相一致,而疾病有限或完全缓解的患者中 CD8+CD57+百分比较低。在处于潜伏疾病的患者中,CD8+CD57+的百分比随时间增加。高数量的 CD8+CD57+与低 CD4:CD8 比值相关。
在 WG 和 MPA 患者中,CD8+CD57+细胞群扩增,鉴定为终末分化的 CD8+细胞。CD57+细胞的患病率与疾病过程有关。到目前为止,CD57 在 CD8+细胞上的功能尚不清楚。然而,这些细胞可能产生某些细胞因子,这些细胞因子在 AAV 的发病机制中起作用。这些数据支持 CD8+T 细胞在原发性血管炎的背景下被激活的假说。